BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30214604)

  • 1. Toll-like receptor agonist rMBP-NAP enhances antitumor cytokines production and CTL activity of peripheral blood mononuclear cells from patients with lung cancer.
    Ding C; Li L; Zhang Y; Ji Z; Zhang C; Liang T; Guo X; Liu X; Kang Q
    Oncol Lett; 2018 Oct; 16(4):4707-4712. PubMed ID: 30214604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor and immunomodulatory effects of recombinant fusion protein rMBP-NAP through TLR-2 dependent mechanism in tumor bearing mice.
    Wang T; Liu X; Ji Z; Men Y; Du M; Ding C; Wu Y; Liu X; Kang Q
    Int Immunopharmacol; 2015 Dec; 29(2):876-883. PubMed ID: 26384537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant protein rMBP-NAP restricts tumor progression by triggering antitumor immunity in mouse metastatic lung cancer.
    Wang T; Du M; Ji Z; Ding C; Wang C; Men Y; Liu S; Liang T; Liu X; Kang Q
    Can J Physiol Pharmacol; 2018 Feb; 96(2):113-119. PubMed ID: 28863272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. rMBP-NAP Suppresses OXA-induced Allergic Dermatitis by Regulating the Th1/Th2 Balance.
    Zheng H; Kang Q; Zhang C; Yang L; Liu X
    Iran J Immunol; 2023 Mar; 20(1):36-44. PubMed ID: 36932908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR agonist rMBP-NAP inhibits B16 melanoma tumor growth via induction of DCs maturation and T-cells cytotoxic response.
    Liu J; Ding C; Wang X; Yang L; Liu X; Kang Q
    Cytotechnology; 2022 Aug; 74(4):459-467. PubMed ID: 36110155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusion expression of Helicobacter pylori neutrophil-activating protein in E.coli.
    Kang QZ; Duan GC; Fan QT; Xi YL
    World J Gastroenterol; 2005 Jan; 11(3):454-6. PubMed ID: 15637768
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Wen SH; Hong ZW; Chen CC; Chang HW; Fu HW
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768994
    [No Abstract]   [Full Text] [Related]  

  • 8. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
    Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
    J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus.
    Iankov ID; Allen C; Federspiel MJ; Myers RM; Peng KW; Ingle JN; Russell SJ; Galanis E
    Mol Ther; 2012 Jun; 20(6):1139-47. PubMed ID: 22334023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of
    Fu HW; Lai YC
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613542
    [No Abstract]   [Full Text] [Related]  

  • 11. [The regulatory function of tumor-infiltrating Th9 cells to anti-tumor activity of CD8(+) T cells in patients with gastric cancer].
    Sun PS; Gao ZJ; Fan LX; Liu YF; Chen BH; Mu SZ; Yan ZQ
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1186-1193. PubMed ID: 36380667
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.
    Radstake TR; Roelofs MF; Jenniskens YM; Oppers-Walgreen B; van Riel PL; Barrera P; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Dec; 50(12):3856-65. PubMed ID: 15593217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
    Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological actions of Sophy beta-glucan (beta-1,3-1,6 glucan), currently available commercially as a health food supplement.
    Ikewaki N; Fujii N; Onaka T; Ikewaki S; Inoko H
    Microbiol Immunol; 2007; 51(9):861-73. PubMed ID: 17895603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-Beta Treatment Differentially Alters TLR2 and TLR4-Dependent Cytokine Production in Multiple Sclerosis Patients.
    Oliveira IBN; Gomes RS; Gomides LF; Dos Santos JC; Carneiro MAD; Ribeiro-Dias F; Diniz DS
    Neuroimmunomodulation; 2019; 26(2):77-83. PubMed ID: 30897575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes of Toll-like Receptor mRNA and Related Cytokines in Patients with Hepatic Alveolar Echinococcosis].
    Abudusalamu A; Tuerhongjiang T; Ma HZ; Zhang H; Zhang H; Abudukaiyoumu M; Li YP; Shadike A; Lin RY; Shao YM; Wen H
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2016 Dec; 34(6):542-6. PubMed ID: 30141853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and evaluation of antibodies against neutrophil-activating protein of Helicobacter pylori in patients with gastric cancer.
    Long M; Luo J; Li Y; Zeng FY; Li M
    World J Gastroenterol; 2009 May; 15(19):2381-8. PubMed ID: 19452583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages.
    Müller E; Christopoulos PF; Halder S; Lunde A; Beraki K; Speth M; Øynebråten I; Corthay A
    Front Immunol; 2017; 8():1383. PubMed ID: 29123526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered IL-10 and TNF-α production in peripheral blood mononuclear cells of systemic lupus erythematosus patients after Toll-like receptor 2, 4, or 9 activation.
    Tsao JT; Hsieh SC; Chiang BL; Yu CL; Lin SC
    Clin Exp Med; 2012 Sep; 12(3):153-8. PubMed ID: 22057691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression of TH2 responses in Trichinella spiralis infection by Helicobacter pylori neutrophil-activating protein.
    Del Prete G; Chiumiento L; Amedei A; Piazza M; D'Elios MM; Codolo G; de Bernard M; Masetti M; Bruschi F
    J Allergy Clin Immunol; 2008 Nov; 122(5):908-913.e5. PubMed ID: 18804852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.